Ifp Advisors, Inc 180 Life Sciences Corp. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022
BUY
$0.81 - $2.53 $586 - $1,831
724 New
724 $2,000
Q2 2022

Aug 12, 2022
SELL
$0.81 - $2.53 $586 - $1,831
-724 Closed
0 $0
Q1 2022

Sep 06, 2022
BUY
$2.53 - $3.9 $1,831 - $2,823
724 New
724 $1,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $141M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email